TLR5 activation induces secretory interleukin-1 receptor antagonist (sIL-1Ra) and reduces inflammasome-associated tissue damage

Mucosal Immunology

Volumn 4, Issue 1, 2011, Pages 102-111

  Carvalho, F A ^a   Aitken, J D ^a   Gewirtz, A T ^a   Vijay Kumar, M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLAGELLIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; TOLL LIKE RECEPTOR 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION REGULATION; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SALMONELLOSIS;

EID: 78649545020     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2010.57     Document Type: Article

References (43)

1. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783-801 (2006).
2. Martinon, F., Mayor, A. & Tschopp, J. The infl ammasomes: Guardians of the body. Annu. Rev. Immunol. 27, 229-265 (2009).
3. Miao, E. A. et al. Cytoplasmic fl agellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat. Immunol. 7, 569-575 (2006).
4. Franchi, L. et al. Cytosolic fl agellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat. Immunol. 7, 576-582 (2006).
5. Lightfi eld, K. L. et al. Critical function for Naip5 in infl ammasome activation by a conserved carboxy-terminal domain of fl agellin. Nat. Immunol. 9, 1171-1178 (2008).
6. Means, T. K., Hayashi, F., Smith, K. D., Aderem, A. & Luster, A. D. The Toll-like receptor 5 stimulus bacterial fl agellin induces maturation and chemokine production in human dendritic cells. J. Immunol. 170, 5165-5175 (2003).
7. Vijay-Kumar, M. et al. Flagellin suppresses epithelial apoptosis and limits disease during enteric infection. Am. J. Pathol. 169, 1686-1700 (2006).
8. Fink, S. L. & Cookson, B. T. Pyroptosis and host cell death responses during Salmonella infection. Cell Microbiol. 9, 2562-2570 (2007).
9. Aksentijevich, I. et al. An autoinfl ammatory disease with defi ciency of the interleukin-1-receptor antagonist. N Engl. J. Med. 360, 2426-2437 (2009).
10. Arend, W. P., Malyak, M., Guthridge, C. J. & Gabay, C. Interleukin-1 receptor antagonist: Role in biology. Annu. Rev. Immunol. 16, 27-55 (1998).
11. Molnarfi, N., Hyka-Nouspikel, N., Gruaz, L., Dayer, J. M. & Burger, D. The production of IL-1 receptor antagonist in IFN-beta-stimulated human monocytes depends on the activation of phosphatidylinositol 3-kinase but not of STAT1. J. Immunol. 174, 2974-2980 (2005).
12. Hirsch, E., Irikura, V. M., Paul, S. M. & Hirsh, D. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc. Natl. Acad. Sci. USA 93, 11008-11013 (1996).
13. Irikura, V. M., Lagraoui, M. & Hirsh, D. The epistatic interrelationships of IL-1, IL-1 receptor antagonist, and the type I IL-1 receptor. J. Immunol. 169, 393-398 (2002).
14. Irikura, V. M., Hirsch, E. & Hirsh, D. Effects of interleukin-1 receptor antagonist overexpression on infection by Listeria monocytogenes. Infect. Immun. 67, 1901-1909 (1999).
15. Vijay-Kumar, M. et al. Deletion of TLR5 results in spontaneous colitis in mice. J. Clin. Invest. 117, 3909-3921 (2007).
16. Vijay-Kumar, M. et al. Toll-like receptor 5-defi cient mice have dysregulated intestinal gene expression and nonspecifi c resistance to Salmonellainduced typhoid-like disease. Infect. Immun. 76, 1276-1281 (2008).
17. Sanders, C. J. et al. Induction of adaptive immunity by fl agellin does not require robust activation of innate immunity. Eur. J. Immunol. 39, 359-371 (2009).
18. Vijay-Kumar, M., Carvalho, F. A., Aitken, J. D. & Gewirtz, A. T. IPAF or TLR5 is necessary and suffi cient for promotion of humoral immunity by fl agellin (in press).
19. Daig, R. et al. Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6. Gut 46, 350-358 (2000).
20. Gewirtz, A. T., Navas, T. A., Lyons, S., Godowski, P. J. & Madara, J. L. Cutting edge: Bacterial fl agellin activates basolaterally expressed TLR5 to induce epithelial proinfl ammatory gene expression. J. Immunol. 167, 1882-1885 (2001).
21. Muhl, H. & Pfeilschifter, J. Anti-infl ammatory properties of pro-infl ammatory interferon-gamma. Int. Immunopharmacol. 3, 1247-1255 (2003).
22. Paulukat, J. et al. Expression and release of IL-18 binding protein in response to IFN-gamma. J. Immunol. 167, 7038-7043 (2001).
23. Yu, Y. et al. TLR5-mediated activation of p38 MAPK regulates epithelial IL-8 expression via posttranscriptional mechanism. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G282-G290 (2003).
24. Gewirtz, A. T. et al. Salmonella typhimurium induces epithelial IL-8 expression via Ca(2+)-mediated activation of the NF-kappaB pathway. J. Clin. Invest. 105, 79-92 (2000).
25. Uematsu, S. et al. Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c+ lamina propria cells. Nat. Immunol. 7, 868-874 (2006).
26. Casini-Raggi, V. et al. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in infl ammatory bowel disease. A novel mechanism of chronic intestinal infl ammation. J. Immunol. 154, 2434-2440 (1995).
27. Sanders, C. J., Moore, D. A. III, Williams, I. R. & Gewirtz, A. T. Both radioresistant and hemopoietic cells promote innate and adaptive immune responses to fl agellin. J. Immunol. 180, 7184-7192 (2008).
28. Fournier, B., Williams, I. R., Gewirtz, A. T. & Neish, A. S. Toll-like receptor 5-dependent regulation of infl ammation in systemic Salmonella enterica Serovar typhimurium infection. Infect. Immun. 77, 4121-4129 (2009).
29. Schmitt, C. K. et al. Absence of all components of the fl agellar export and synthesis machinery differentially alters virulence of Salmonella enterica serovar Typhimurium in models of typhoid fever, survival in macrophages, tissue culture invasiveness, and calf enterocolitis. Infect. Immun. 69, 5619-5625 (2001).
30. Dinarello, C. A. Biologic basis for interleukin-1 in disease. Blood 87, 2095-2147 (1996).
31. Weber, A., Wasiliew, P. & Kracht, M. Interleukin-1beta (IL-1beta) processing pathway. Sci. Signal 3, cm2.
32. Arend, W. P. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 13, 323-340 (2002).
33. Dinarello, C. A. The role of the interleukin-1-receptor antagonist in blocking infl ammation mediated by interleukin-1. N Engl. J. Med. 343, 732-734 (2000).
34. Arend, W. P. Interleukin-1 receptor antagonist. Adv. Immunol. 54, 167-227 (1993).
35. Mayer-Barber, K. D. et al. Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 184, 3326-3330.
36. Ivison, S. M. et al. TLR5 is not required for fl agellin-mediated exacerbation of DSS colitis. Infl amm. Bowel. Dis. 16, 401-409 (2010).
37. Vijay-Kumar, M. et al. Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science 328, 228-231 (2010).
38. Hayashi, F. et al. The innate immune response to bacterial fl agellin is mediated by Toll-like receptor 5. Nature 410, 1099-1103 (2001).
39. Hultgren, O. H., Berglund, M., Bjursten, M. & Hultgren Hornquist, E. Serum interleukin-1 receptor antagonist is an early indicator of colitis onset in Galphai2-defi cient mice. World J. Gastroenterol. 12, 621-624 (2006).
40. Boudeau, J., Glasser, A. L., Masseret, E., Joly, B. & Darfeuille-Michaud, A. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect. Immun. 67, 4499-4509 (1999).
41. Glasser, A. L. et al. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect. Immun. 69, 5529-5537 (2001).
42. Barthel, M. et al. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 71, 2839-2858 (2003).
43. Castaneda, F. E. et al. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: Central role of epithelial-derived MMP. Gastroenterology 129, 1991-2008 (2005).